TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy

NCT06013839 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

DMD-Associated Dilated Cardiomyopathy

Interventions

DRUG: talfirastide

Sponsor

Constant Therapeutics LLC